A generic version of teneligliptin works identically to the brand-name drug Tenelia in delivering medication to the bloodstream, according to a 2026 study of 52 healthy Chinese volunteers. Research shows the generic tablet met all regulatory standards for bioequivalence, performing the same whether taken while fasting or after eating, which means patients could potentially save money by switching to the generic without losing effectiveness.
Researchers tested whether a new generic version of teneligliptin, a diabetes medication widely used in Asia, works the same way in the body as the brand-name drug Tenelia. According to Gram Research analysis, 52 healthy Chinese volunteers took both versions of the drug in two different settings: once while fasting and once after eating. The study found that the generic tablet performed identically to the brand-name version, meaning patients could potentially save money by switching to the generic without losing effectiveness. This research is important because it shows that cheaper alternatives can be just as reliable as expensive brand-name medications for managing type 2 diabetes.
Key Statistics
A 2026 randomized controlled trial of 52 healthy Chinese volunteers found that a generic teneligliptin tablet was bioequivalent to the brand-name Tenelia, with all measurements of drug absorption falling within the regulatory standard of 80-125%.
Research shows the generic teneligliptin tablet performed identically to the brand-name version in both fasting and fed conditions, with no serious adverse events reported in any of the 52 study participants.
According to a 2026 bioequivalence study, the generic teneligliptin formulation delivered the same peak blood concentration and total drug exposure as Tenelia, supporting its use as a cost-effective alternative for type 2 diabetes treatment.
The Quick Take
- What they studied: Whether a generic version of teneligliptin (a diabetes medication) works exactly the same as the brand-name version called Tenelia in the human body
- Who participated: 52 healthy Chinese adults, split into two groups of 26 people each, who received both the generic and brand-name versions of the drug on different days
- Key finding: The generic tablet worked identically to the brand-name drug in both fasting and fed conditions, with all measurements falling within the acceptable range of equivalence (80-125%)
- What it means for you: If you take teneligliptin for type 2 diabetes, switching to a generic version could save you money while maintaining the same health benefits, though you should always consult your doctor before changing medications
The Research Details
This was a carefully controlled experiment called a randomized crossover trial. Each of the 52 healthy volunteers received both the generic tablet and the brand-name Tenelia tablet at different times, separated by 7 days. Half the participants took the generic version first, then the brand-name version, while the other half did the opposite. This design helps researchers see if the order matters and ensures a fair comparison. The study was conducted in two separate phases: one where participants fasted before taking the medication, and another where they ate a meal first. This matters because food can affect how medications are absorbed in the body.
Testing medications under both fasting and fed conditions is important because real-world patients don’t always take their pills on an empty stomach. By testing both scenarios, researchers can confirm the generic works reliably regardless of when you eat. The crossover design, where each person takes both versions, is particularly strong because it eliminates differences between people as a source of error. This makes it easier to spot real differences between the two products if they exist.
This study has several strengths that make its findings reliable. The researchers used a sophisticated laboratory method called LC-MS/MS to measure drug levels in the blood, which is highly accurate. The study was registered in an official clinical trial database before completion, which prevents researchers from cherry-picking favorable results. All participants were healthy volunteers, which means the results show how the drugs work in ideal conditions. However, the study only included Chinese volunteers, so results may not apply equally to other populations. The relatively small sample size of 52 people is typical for this type of drug comparison study but means results should be confirmed in larger populations.
What the Results Show
The generic tablet and brand-name Tenelia performed virtually identically in the body. Researchers measured three key indicators of how much drug reaches the bloodstream and how quickly: the total amount of drug absorbed over time (AUC0-t and AUC0-∞) and the peak concentration (Cmax). For all three measurements, the generic version fell within the regulatory standard of 80-125% of the brand-name version’s performance. This means the generic is considered bioequivalent, a technical term meaning it delivers the same amount of active medication to your body as the brand-name drug. The results held true whether participants took the medication while fasting or after eating a meal. No serious side effects occurred in either group during the study.
The study also tracked minor adverse events, or unwanted effects, that participants experienced. No serious adverse events were reported in any participant. This suggests both formulations are well-tolerated in healthy individuals. The fact that results were consistent across both fasting and fed conditions is particularly important because it means patients don’t need to worry about timing their doses relative to meals.
This research fills an important gap in the scientific literature. While teneligliptin is widely prescribed in Asia for type 2 diabetes, there has been limited information about whether generic versions work the same as the brand-name drug in Chinese patients specifically. Previous studies in other populations have shown that generic diabetes medications can be equivalent to brand-name versions, and this study confirms that pattern holds true for teneligliptin in a Chinese population.
The study only included 52 healthy volunteers, which is a relatively small number. Healthy people may respond differently to medications than people who actually have type 2 diabetes or other health conditions. The study was conducted only in China with Chinese participants, so the results may not apply equally to other ethnic groups or populations. The study was also relatively short-term, measuring only how the body processes a single dose, rather than tracking long-term effects of repeated doses. Finally, the study was registered after it was completed, which is less ideal than registering before starting research.
The Bottom Line
Based on this research, the generic teneligliptin tablet appears to be a reliable, cost-effective alternative to the brand-name Tenelia for people with type 2 diabetes. The evidence is strong that the generic delivers the same amount of active medication to your body. However, any decision to switch medications should be made in consultation with your doctor, who knows your complete medical history. Your doctor may have specific reasons for recommending one formulation over another.
This research is most relevant to people in Asia, particularly China, who take teneligliptin for type 2 diabetes and are considering switching to a generic version to save money. Healthcare providers and insurance companies should also pay attention, as this research supports the use of generic teneligliptin as a cost-saving measure. People with type 2 diabetes in other regions may find this information useful if similar generic versions become available in their countries.
Since this study measured how the body processes a single dose, it doesn’t tell us about long-term effects. If you switch to the generic version, you should expect similar blood sugar control as you experienced with the brand-name drug. However, it typically takes 2 to 4 weeks of consistent use to see the full effects of any diabetes medication. If you notice changes in your blood sugar control after switching, contact your doctor.
Frequently Asked Questions
Is the generic version of teneligliptin as effective as the brand-name drug?
Yes, a 2026 study of 52 healthy volunteers found the generic tablet was bioequivalent to Tenelia, meaning it delivers the same amount of active medication to your bloodstream. All measurements fell within regulatory standards for equivalence.
Does it matter if I take teneligliptin with food or on an empty stomach?
No, research shows teneligliptin works equally well whether you take it while fasting or after eating. The generic and brand-name versions both performed identically in both conditions, so timing relative to meals doesn’t affect effectiveness.
Can I safely switch from brand-name Tenelia to the generic version?
This study supports the generic as an equivalent alternative, but you should consult your doctor before switching any medication. Your doctor knows your complete health history and can advise whether switching is appropriate for your situation.
What side effects should I watch for with generic teneligliptin?
This study found no serious adverse events in 52 healthy volunteers taking either version. However, this study involved healthy people, not those with diabetes. Ask your doctor about potential side effects specific to your health situation.
How long does it take to see results after switching to generic teneligliptin?
Since the generic delivers the same medication as the brand-name version, you should expect similar blood sugar control. Diabetes medications typically show full effects within 2 to 4 weeks of consistent use. Contact your doctor if you notice changes in your blood sugar control.
Want to Apply This Research?
- Track your fasting blood glucose levels daily and record which medication version you’re taking, noting the date you switch from brand-name to generic. This creates a personal record showing whether your blood sugar control remains stable after switching.
- If your doctor approves switching to the generic version, use the app to set a reminder for your daily dose at the same time each day, whether you’ve eaten or not. The research shows the medication works equally well in both conditions, so consistency matters more than timing relative to meals.
- Over 8 to 12 weeks after switching to the generic, track your blood glucose readings, any side effects, and how you feel overall. Compare these metrics to your baseline from before the switch to confirm the generic is working as effectively as the brand-name version for your individual situation.
This research evaluates the pharmaceutical equivalence of a generic teneligliptin tablet in healthy volunteers. It does not replace medical advice from your healthcare provider. Before switching from a brand-name medication to a generic version, consult your doctor, who can assess whether the change is appropriate for your individual health situation, medical history, and diabetes management plan. This study was conducted in healthy Chinese adults and may not apply equally to other populations or to people with type 2 diabetes or other medical conditions. Do not make medication changes without professional medical guidance.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.